Media Highlights and Announcements
Bio WorldNovember 30, 2021
Medtech newcomer Artrya Ltd. listed on the Australian Securities Exchange (ASX) in an AU$40 million (US$28.6 million) initial public offering.
The Motley FoolNovember 29, 2021
Move over Appen, the new AI player in town went gangbusters on its first day as a public company.
November 26, 2021
Fresh from its ASX debut, AYA’s mission is simple: it’s out to more accurately and less invasively detect signs of heart disease with the power of artificial intelligence (AI).
Business NewsNovember 26, 2021
Local medtech Artya has listed on the stock exchange, having earlier raised $40 million through an IPO to help commercialise its cardiac imaging software.
The Market HeraldNovember 26, 2021
Artrya (AYA), an artificial intelligence medical technology business, has started trading on the ASX after the successful completion of its initial public offering (IPO).
StockheadNovember 26, 2021
The medical technology company listed today after raising $40 million at $1.35. Its share price is up ~13% to $1.52.
November 24, 2021
AI medical technology company Artrya Limited is announcing its partnership with leading global commercial services provider EVERSANA Life Sciences LLC.
November 15, 2021
In this Stockhead article, Tim Boreham dives into Artrya as a company and shares his thoughts in the current $100M market valuation. He also speaks on Artya’s recent accomplishments as well as goals in the months and years to come.
November 09, 2021
Artrya has been accepted onto the UK National Health Service Shared Business Services (NHS SBS) Framework as a supplier of artificial intelligence software and platforms.